etanidazole

PreclinicalSmall molecule

NNational Cancer Institute (NCI)

etanidazole is one of 51 small molecule programs targeting Malignant Glioma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Malignant GliomaActive, not recruiting

Malignant GliomaPreclinical

Active, not recruiting

Competition

Competitive Landscape

199 competitors in Malignant Glioma

#DrugCompanyPhaseTrials

Bicnu

MMelissa K Accordino

Phase 3

9 2

Ceenu

AAzurity Pharmaceuticals

Phase 3

4 3

Oncovin

EEastern Cooperative Oncology Group

Phase 3

1 4

Thalomid

Bristol-Myers Squibb

Phase 2

3 5

Camptosar

Pfizer

Phase 2

3 6

Avastin

BBio-Thera Solutions

Phase 2

12 7

Sutent

Pfizer

Phase 2

2 8

Leukine

Sanofi

Phase 2

2 9

Zofran

Novartis

Phase 2

2 10

Imjudo

AstraZeneca

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Intraperitoneal1 trial

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Terminated·NNational Cancer Institute (NCI)·N/A·NCT00028782·80 enrolled

Malignant Glioma1 trial

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

Terminated·NNational Cancer Institute (NCI)·N/A·NCT00430079·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for etanidazole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — etanidazole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for etanidazole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Cancer Institute (NCI) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Cancer Institute (NCI)

etanidazole

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Intraperitoneal1 trial

Malignant Glioma1 trial

References

Drug Info

Quick Facts

Related News